[1]
D.-L. Ng, “Rapamycin pre-treatment abrogates Tumour Necrosis Factor-α down-regulatory effects on LXR-α and PXR mRNA expression via inhibition of c-Jun N-terminal kinase 1 activation in HepG2 cells”, Electron. J. Biotechnol., vol. 14, no. 3, May 2011.